Feasibility and acceptability of a brief routine weight management intervention for postnatal women embedded within the national child immunisation programme in primary care: randomised controlled cluster feasibility trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
01 Sep 2020
Historique:
received: 18 01 2020
accepted: 12 08 2020
entrez: 3 9 2020
pubmed: 3 9 2020
medline: 22 6 2021
Statut: epublish

Résumé

The prevalence of obesity in women continues to rise and pregnancy is a high-risk time for excessive weight gain. The period after childbirth represents an opportunity to offer women support to manage their weight. The primary aim here was to investigate the acceptability and feasibility of delivering a self-management intervention to postnatal women to support weight loss, embedded within the national child immunisation programme. The research involved a randomised controlled cluster feasibility trial. Data were collected at baseline and 3 months later. Twenty-eight postnatal women living with overweight or obesity were recruited via Birmingham Women Hospital or general practices. Babies are routinely immunised at 2, 3 and 4 months of age; the intervention was embedded within these appointments. The intervention involved brief motivation/support by practice nurses to encourage participants to make healthier lifestyle choices through self-monitoring of weight and signposting to an online weight management programme, when they attended their practice to have their child immunised. The role of the nurse was to provide external accountability for weight loss. Participants were asked to weigh themselves weekly and record this on a record card or using the online programme. The weight goal was for participants to lose 0.5 to 1 kg per week. Usual care received a healthy lifestyle leaflet. The primary outcome was the feasibility of a phase III trial to test the subsequent effectiveness of the intervention, as assessed against three stop-go traffic light criteria (recruitment, adherence to regular self-weighing and registration with an online weight management programme). The traffic light stop-go criteria results were red for recruitment (28/80, 35% of target), amber for registration with the online weight loss programme (9/16, 56%) and green for adherence to weekly self-weighing (10/16, 63%). Nurses delivered the intervention with high fidelity. Whilst participants and nurses followed the trial protocol well and adherence to self-weighing was acceptable, recruitment was challenging and there is scope to improve engagement with the online weight management programme component of the intervention. ISRCTN 12209332 . Registration date is 04/12/18.

Sections du résumé

BACKGROUND BACKGROUND
The prevalence of obesity in women continues to rise and pregnancy is a high-risk time for excessive weight gain. The period after childbirth represents an opportunity to offer women support to manage their weight. The primary aim here was to investigate the acceptability and feasibility of delivering a self-management intervention to postnatal women to support weight loss, embedded within the national child immunisation programme.
METHODS METHODS
The research involved a randomised controlled cluster feasibility trial. Data were collected at baseline and 3 months later. Twenty-eight postnatal women living with overweight or obesity were recruited via Birmingham Women Hospital or general practices. Babies are routinely immunised at 2, 3 and 4 months of age; the intervention was embedded within these appointments. The intervention involved brief motivation/support by practice nurses to encourage participants to make healthier lifestyle choices through self-monitoring of weight and signposting to an online weight management programme, when they attended their practice to have their child immunised. The role of the nurse was to provide external accountability for weight loss. Participants were asked to weigh themselves weekly and record this on a record card or using the online programme. The weight goal was for participants to lose 0.5 to 1 kg per week. Usual care received a healthy lifestyle leaflet. The primary outcome was the feasibility of a phase III trial to test the subsequent effectiveness of the intervention, as assessed against three stop-go traffic light criteria (recruitment, adherence to regular self-weighing and registration with an online weight management programme).
RESULTS RESULTS
The traffic light stop-go criteria results were red for recruitment (28/80, 35% of target), amber for registration with the online weight loss programme (9/16, 56%) and green for adherence to weekly self-weighing (10/16, 63%). Nurses delivered the intervention with high fidelity.
DISCUSSION CONCLUSIONS
Whilst participants and nurses followed the trial protocol well and adherence to self-weighing was acceptable, recruitment was challenging and there is scope to improve engagement with the online weight management programme component of the intervention.
TRIAL REGISTRATION BACKGROUND
ISRCTN 12209332 . Registration date is 04/12/18.

Identifiants

pubmed: 32873323
doi: 10.1186/s13063-020-04673-9
pii: 10.1186/s13063-020-04673-9
pmc: PMC7466790
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

757

Subventions

Organisme : Department of Health
ID : 15/184/14
Pays : United Kingdom
Organisme : Health Technology Assessment Programme
ID : 15/184/14

Références

Qual Life Res. 2012 Feb;21(1):167-76
pubmed: 21598064
BMJ Open. 2019 Sep 17;9(9):e030174
pubmed: 31530608
BMJ Open. 2015 Aug 07;5(8):e008546
pubmed: 26254471
Int J Obes Relat Metab Disord. 2003 Dec;27(12):1516-22
pubmed: 14634683
J Med Internet Res. 2017 May 12;19(5):e160
pubmed: 28500022
Addiction. 2012 Aug;107(8):1431-40
pubmed: 22340523
Obes Rev. 2019 Jun;20(6):829-841
pubmed: 30941875
Trials. 2014 Jul 03;15:264
pubmed: 24993581
Lancet. 2006 Sep 30;368(9542):1164-70
pubmed: 17011943
Obesity (Silver Spring). 2013 Sep;21(9):1789-97
pubmed: 23512320
Arch Intern Med. 1990 Mar;150(3):665-72
pubmed: 2310286
Obes Res Clin Pract. 2016 Sep - Oct;10(5):493-519
pubmed: 26896865
PLoS One. 2018 Aug 10;13(8):e0202072
pubmed: 30096203
Qual Health Res. 2009 Jun;19(6):815-28
pubmed: 19365099
Ann Behav Med. 2005 Dec;30(3):210-6
pubmed: 16336072
J Med Internet Res. 2017 Oct 13;19(10):e337
pubmed: 29030327
Age Ageing. 2017 Nov 1;46(6):895-903
pubmed: 28481964
Obesity (Silver Spring). 2013 Dec;21(12):2429-36
pubmed: 23512914
Matern Child Health J. 2019 Oct;23(10):1400-1413
pubmed: 31222598
JMIR Hum Factors. 2015 May 19;2(1):e8
pubmed: 27026372
Lancet Diabetes Endocrinol. 2015 Oct;3(10):767-77
pubmed: 26165396
J Midwifery Womens Health. 2004 Mar-Apr;49(2):138-44
pubmed: 15010667
Lancet. 2011 Aug 27;378(9793):815-25
pubmed: 21872750
J Nutr. 2004 Sep;134(9):2372-80
pubmed: 15333731
J Pregnancy. 2013;2013:787032
pubmed: 23533762
BMC Res Notes. 2018 Mar 27;11(1):203
pubmed: 29587868
Eat Disord. 2002 Summer;10(2):103-13
pubmed: 16864251
Obstet Gynecol. 2013 Nov;122(5):999-1009
pubmed: 24104777
BMJ. 2014 Feb 10;348:g1285
pubmed: 24513442
Int J Behav Nutr Phys Act. 2015 Aug 21;12:104
pubmed: 26293454
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Am Diet Assoc. 2011 Jan;111(1):92-102
pubmed: 21185970
Lancet. 2016 Nov 19;388(10059):2492-2500
pubmed: 27789061
Am J Hypertens. 2015 Oct;28(10):1209-21
pubmed: 25725092
BMC Public Health. 2016 Jul 22;16:625
pubmed: 27449265
Lancet Diabetes Endocrinol. 2016 Oct;4(10):821-8
pubmed: 27474214
BMJ Open. 2020 Feb 16;10(2):e033027
pubmed: 32066605
Contemp Clin Trials. 2011 Jul;32(4):505-11
pubmed: 21382511
Med Sci Sports Exerc. 2004 Oct;36(10):1750-60
pubmed: 15595297
Int J Obes Relat Metab Disord. 2003 Jan;27(1):117-27
pubmed: 12532163
Cancer. 2014 Apr 1;120 Suppl 7:1091-6
pubmed: 24643646
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Obstet Gynecol. 2005 Dec;106(6):1349-56
pubmed: 16319262
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Obstet Gynecol Neonatal Nurs. 2012 Jan;41(1):57-70
pubmed: 22834722
Cochrane Database Syst Rev. 2018 Feb 22;2:MR000013
pubmed: 29468635

Auteurs

A J Daley (AJ)

School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, Leicestershire, LE11 3TU, UK. a.daley@lboro.ac.uk.

K Jolly (K)

Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

H Bensoussane (H)

Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

N Ives (N)

Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

S A Jebb (SA)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

S Tearne (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

S M Greenfield (SM)

Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

L Yardley (L)

School of Psychological Science, University of Bristol, Bristol, BS8 1TH, UK.
Department of Psychology, University of Southampton, Southampton, S017 1BJ, UK.

P Little (P)

Faculty of Medicine, University of Southampton, Southampton, SO17 1BJ, UK.

N Tyldesley-Marshall (N)

School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, Leicestershire, LE11 3TU, UK.
Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

R V Pritchett (RV)

Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

E Frew (E)

Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

H M Parretti (HM)

Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Norwich Medical School, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH